Insider Transactions Reported by 13 Insiders of
SUPERNUS PHARMACEUTICALS, INC.
-
Symbol
-
SUPN on Nasdaq
-
Location
-
Rockville, MD
Quick Takeaways
- SUPN - SUPERNUS PHARMACEUTICALS, INC. has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$32,269,469.
- Recent transaction rows are available for direct filing-level review.
What Changed
- Buy value: ; sell value: $32,269,469.
- Net share flow: <span class="text-red-600">-682,797</span>.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Filed on Form 4
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Insiders trading volume in the past year
Insider trading buckets (0-12 months)
SUPERNUS PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:
| Name |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Valuation |
Report Date |
| Jack A. Khattar |
President, CEO, Director |
$113,252,362 |
-$20,309,838 |
-15% |
Mixed |
13 Mar 2026 |
| Charles W. Newhall III |
Director |
$6,291,759 |
-$1,539,270 |
-20% |
Mixed |
24 Feb 2026 |
| Frederick M. Hudson |
Director |
$3,235,159 |
-$586,858 |
-15% |
Mixed |
12 Mar 2026 |
| Tami Tillotson Martin |
Sr. V.P., Regulatory Affairs |
$2,631,048 |
|
|
Mixed |
23 Feb 2024 |
| John M. Siebert |
Director |
$2,555,624 |
|
|
Mixed |
23 Feb 2024 |
| Georges Gemayel |
Director |
$1,623,339 |
-$1,002,811 |
-38% |
Mixed |
05 Mar 2026 |
| Carrolee Barlow |
Director |
$1,509,894 |
|
|
Mixed |
24 Feb 2026 |
| Frank Mottola |
SVP, Chief Tech. Ops. Officer |
$1,138,181 |
-$1,947,714 |
-63% |
Mixed |
06 Mar 2026 |
| Padmanabh P. Bhatt |
Sr. VP of IP, CSO |
$958,256 |
-$5,419,984 |
-85% |
Mixed |
16 Mar 2026 |
| Jonathan Rubin |
SVP, Chief Medical Officer |
$774,130 |
|
|
Mixed |
25 Feb 2026 |
| Timothy C. Dec |
Senior Vice-President & CFO |
$620,801 |
-$524,092 |
-46% |
Mixed |
06 Mar 2026 |
| Bethany Sensenig |
Director |
$177,658 |
-$455,105 |
-72% |
Mixed |
19 Feb 2026 |
| William Todd Horich |
SVP, Commercial Operations |
$0 |
-$483,797 |
-100% |
Mixed |
06 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for SUPERNUS PHARMACEUTICALS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider |
Symbol |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares Owned |
Date |
Ownership |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Sale |
-29.8% |
$359,621 |
$49.60 |
-7,250 |
17,044 |
18 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Options Exercise |
42.5% |
|
|
7,250 |
24,294 |
18 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Employee Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-7,250 |
0 |
18 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Sale |
-74.6% |
$2,514,886 |
$50.30 |
-50,000 |
17,044 |
17 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Options Exercise |
293.4% |
|
|
50,000 |
67,044 |
17 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Employee Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-50,000 |
0 |
17 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Sale |
-74.6% |
$2,513,925 |
$50.28 |
-50,000 |
17,044 |
16 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Options Exercise |
293.4% |
|
|
50,000 |
67,044 |
16 Mar 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Employee Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-50,000 |
0 |
16 Mar 2026 |
Direct |
| Jack A. Khattar |
SUPN |
Common Stock |
Sale |
-3.52% |
$1,763,124 |
$50.38 |
-35,000 |
958,100 |
13 Mar 2026 |
By the KBT Trust |
| Jack A. Khattar |
SUPN |
Common Stock |
Other |
-1.24% |
|
|
-12,500 |
993,100 |
13 Mar 2026 |
By the KBT Trust |
| Jack A. Khattar |
SUPN |
Common Stock |
Other |
1.02% |
|
|
12,500 |
1,241,144 |
13 Mar 2026 |
Direct |
| Frederick M. Hudson |
SUPN |
Common Stock |
Sale |
-8.16% |
$271,725 |
$50.61 |
-5,369 |
60,413 |
12 Mar 2026 |
Direct |
| William Todd Horich |
SUPN |
Common Stock |
Sale |
-100% |
$244,145 |
$55.00 |
-4,439 |
0 |
10 Mar 2026 |
Direct |
| Frank Mottola |
SUPN |
Common Stock |
Sale |
-8.09% |
$87,074 |
$53.65 |
-1,623 |
18,440 |
09 Mar 2026 |
Direct |
| William Todd Horich |
SUPN |
Common Stock |
Sale |
-50% |
$239,652 |
$54.00 |
-4,438 |
4,439 |
09 Mar 2026 |
Direct |
| Jack A. Khattar |
SUPN |
Common Stock |
Tax liability |
-1.33% |
|
|
-16,574 |
1,228,644 |
06 Mar 2026 |
Direct |
| Jack A. Khattar |
SUPN |
Common Stock |
Options Exercise |
3.2% |
|
|
38,640 |
1,245,218 |
06 Mar 2026 |
Direct |
| Jack A. Khattar |
SUPN |
Performance Share Unit |
Options Exercise |
-100% |
|
|
-38,640 |
0 |
06 Mar 2026 |
Direct |
| Frank Mottola |
SUPN |
Common Stock |
Tax liability |
-8.2% |
|
|
-1,793 |
20,063 |
06 Mar 2026 |
Direct |
| Frank Mottola |
SUPN |
Common Stock |
Options Exercise |
20.7% |
|
|
3,750 |
21,856 |
06 Mar 2026 |
Direct |
| Frank Mottola |
SUPN |
Performance Share Unit |
Options Exercise |
-100% |
|
|
-3,750 |
0 |
06 Mar 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Common Stock |
Tax liability |
-30.1% |
|
|
-2,883 |
6,682 |
06 Mar 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Common Stock |
Options Exercise |
163% |
|
|
6,000 |
9,682 |
06 Mar 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Performance Share Unit |
Options Exercise |
-100% |
|
|
-6,000 |
0 |
06 Mar 2026 |
Direct |
| William Todd Horich |
SUPN |
Common Stock |
Tax liability |
-35.6% |
|
|
-3,455 |
6,241 |
06 Mar 2026 |
Direct |
| William Todd Horich |
SUPN |
Common Stock |
Options Exercise |
301.1% |
|
|
7,500 |
9,991 |
06 Mar 2026 |
Direct |
| William Todd Horich |
SUPN |
Performance Share Unit |
Options Exercise |
-100% |
|
|
-7,500 |
0 |
06 Mar 2026 |
Direct |
| Georges Gemayel |
SUPN |
Common Stock |
Sale |
-24.4% |
$465,711 |
$53.00 |
-8,787 |
27,277 |
06 Mar 2026 |
Direct |
| Georges Gemayel |
SUPN |
Common Stock |
Options Exercise |
28.1% |
|
|
7,905 |
36,064 |
06 Mar 2026 |
Direct |
| Georges Gemayel |
SUPN |
Director Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-7,905 |
0 |
06 Mar 2026 |
Direct |
| Georges Gemayel |
SUPN |
Common Stock |
Sale |
-26.2% |
$537,100 |
$53.71 |
-10,000 |
28,159 |
05 Mar 2026 |
Direct |
| Jack A. Khattar |
SUPN |
Performance Share Unit |
Award |
|
|
|
38,640 |
38,640 |
28 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Performance Share Unit |
Award |
|
|
|
6,000 |
3,000 |
28 Feb 2026 |
Direct |
| Frank Mottola |
SUPN |
Performance Share Unit |
Award |
|
|
|
3,750 |
3,750 |
28 Feb 2026 |
Direct |
| Frank Mottola |
SUPN |
Common Stock |
Tax liability |
-5.12% |
|
|
-977 |
18,106 |
25 Feb 2026 |
Direct |
| Frank Mottola |
SUPN |
Common Stock |
Award |
10.9% |
|
|
1,875 |
19,083 |
25 Feb 2026 |
Direct |
| Frank Mottola |
SUPN |
Restricted Stock Unit |
Disposed to Issuer |
-50% |
|
|
-1,875 |
1,875 |
25 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Common Stock |
Tax liability |
-20% |
|
|
-1,279 |
5,115 |
25 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Common Stock |
Award |
64.2% |
|
|
2,500 |
6,394 |
25 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Restricted Stock Unit |
Disposed to Issuer |
-50% |
|
|
-2,500 |
2,500 |
25 Feb 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Tax liability |
-3.67% |
|
|
-650 |
17,044 |
25 Feb 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Common Stock |
Award |
7.6% |
|
|
1,250 |
17,694 |
25 Feb 2026 |
Direct |
| Padmanabh P. Bhatt |
SUPN |
Restricted Stock Unit |
Disposed to Issuer |
-50% |
|
|
-1,250 |
1,250 |
25 Feb 2026 |
Direct |
| Jonathan Rubin |
SUPN |
Common Stock |
Tax liability |
-4.82% |
|
|
-675 |
13,341 |
25 Feb 2026 |
Direct |
| Jonathan Rubin |
SUPN |
Common Stock |
Award |
9.79% |
|
|
1,250 |
14,016 |
25 Feb 2026 |
Direct |
| Jonathan Rubin |
SUPN |
Restricted Stock Unit |
Disposed to Issuer |
-50% |
|
|
-1,250 |
1,250 |
25 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Common Stock |
Tax liability |
-52.3% |
|
|
-2,369 |
2,160 |
24 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Common Stock |
Award |
583.2% |
|
|
4,625 |
5,418 |
24 Feb 2026 |
Direct |
| Timothy C. Dec |
SUPN |
Restricted Stock Unit |
Disposed to Issuer |
-100% |
|
|
-4,625 |
0 |
24 Feb 2026 |
Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.